Technological advancements in glucose monitoring and artificial pancreas systems for shaping diabetes care

被引:0
|
作者
Ghosh, Neha [1 ]
Verma, Saurabh [1 ]
机构
[1] Amity Univ, Amity Inst Pharm, Ctr Ind Pharm & Drugs Regulatory Affairs, Noida, India
关键词
Diabetes mellitus; glucose monitoring; continuous glucose monitoring; artificial pancreas; technological; advancements; FREE-LIVING CONDITIONS; BLOOD-GLUCOSE; LOOP; IMPACT; ADULTS; HYPOGLYCEMIA; MULTICENTER; MANAGEMENT;
D O I
10.1080/03007995.2024.2422005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The management of diabetes mellitus has undergone remarkable progress with the introduction of cutting-edge technologies in glucose monitoring and artificial pancreas systems. These innovations have revolutionized diabetes care, offering patients more precise, convenient, and personalized management solutions that significantly improve their quality of life. This review aims to provide a comprehensive overview of recent technological advancements in glucose monitoring devices and artificial pancreas systems, focusing on their transformative impact on diabetes care. A detailed review of the literature was conducted to examine the evolution of glucose monitoring technologies, from traditional invasive methods to more advanced systems. The review explores minimally invasive techniques such as continuous glucose monitoring (CGM) systems and flash glucose monitoring (FGM) systems, which have already been proven to enhance glycemic control and reduce the risk of hypoglycemia. In addition, emerging non-invasive glucose monitoring technologies, including optical, electrochemical, and electro-mechanical methods, were evaluated. These techniques are paving the way for more patient-friendly options that eliminate the need for frequent finger-prick tests, thereby improving adherence and ease of use. Advancements in closed-loop artificial pancreas systems, which integrate CGM with automated insulin delivery, were also examined. These systems, often referred to as "hybrid closed-loop" or "automated insulin delivery" systems, represent a significant leap forward in diabetes care by automating the process of insulin dosing. Such advancements aim to mimic the natural function of the pancreas, allowing for better glucose regulation without the constant need for manual interventions by the patient. Technological breakthroughs in glucose monitoring and artificial pancreas systems have had a profound impact on diabetes management, providing patients with more accurate, reliable, and individualized treatment options. These innovations hold the potential to significantly improve glycemic control, reduce the incidence of diabetes-related complications, and ultimately enhance the quality of life for individuals living with diabetes. Researchers are continually exploring novel methods to measure glucose more effectively and with greater convenience, further refining the future of diabetes care. Researchers are also investigating the integration of artificial intelligence and machine learning algorithms to further enhance the precision and predictive capabilities of glucose monitoring and insulin delivery systems. With ongoing advancements in sensor technology, connectivity, and data analytics, the future of diabetes care promises to deliver even more seamless, real-time management, empowering patients with greater autonomy and improved health outcomes.
引用
收藏
页码:2095 / 2107
页数:13
相关论文
共 50 条
  • [21] Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story
    Bally, Lia
    Thabit, Hood
    Hovorka, Roman
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 544 (02) : 309 - 318
  • [22] Review of Reinforcement Learning-Based Control Algorithms in Artificial Pancreas Systems for Diabetes Mellitus Management
    Denes-Fazakas, Lehel
    Fazakas, Gyozo Dates
    Eigner, Gyorgy
    Kovacs, Levente
    Szilagyi, Laszlo
    18TH INTERNATIONAL SYMPOSIUM ON APPLIED COMPUTATIONAL INTELLIGENCE AND INFORMATICS, SACI 2024, 2024, : 565 - 571
  • [23] Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring
    Ramkissoon, Charrise M.
    Herrero, Pau
    Bondia, Jorge
    Vehi, Josep
    SENSORS, 2018, 18 (03):
  • [24] Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient
    Forlenza, Gregory P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (04) : 206 - 208
  • [25] Continuous glucose monitoring systems for type 1 diabetes mellitus
    Langendam, Miranda W.
    Luijf, Yoeri M.
    Hooft, Lotty
    DeVries, J. Hans
    Mudde, Aart H.
    Scholten, Rob J. P. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
  • [26] Virtual visits and the use of continuous glucose monitoring for diabetes care in the era of COVID-19
    Underwood, Patricia
    Hibben, Jennifer
    Gibson, Jolynn
    DiNardo, Monica
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2022, 34 (03) : 586 - 596
  • [27] A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas
    Hirsch, Irl B.
    Balo, Andrew K.
    Sayer, Kevin
    Garcia, Arturo
    Buckingham, Bruce A.
    Peyser, Thomas A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 : S38 - S48
  • [28] Bihormonal Artificial Pancreas With Closed-Loop Glucose Control vs Current Diabetes Care After Total Pancreatectomy A Randomized Clinical Trial
    van Veldhuisen, Charlotte L.
    Latenstein, Anouk E. J.
    Blauw, Helga
    Vlaskamp, Lyan B.
    Klaassen, Michel
    Lips, Daan J.
    Bonsing, Bert A.
    van der Harst, Erwin
    Stommel, Martijn W. J.
    Bruno, Marco J.
    van Santvoort, Hjalmar C.
    van Eijck, Casper H. J.
    van Dieren, Susan
    Busch, Olivier R.
    Besselink, Marc G.
    DeVries, J. Hans
    JAMA SURGERY, 2022, 157 (10) : 950 - 957
  • [29] Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems
    Lin, Yu Kuei
    Groat, Danielle
    Chan, Owen
    Hung, Man
    Sharma, Anu
    Varner, Michael W.
    Gouripeddi, Ramkiran
    Facelli, Julio C.
    Fisher, Simon J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (11) : 787 - 793
  • [30] Dual-hormone artificial pancreas for glucose control in type 1 diabetes: A meta-analysis
    Zeng, Baoqi
    Jia, Hao
    Gao, Le
    Yang, Qingqing
    Yu, Kai
    Sun, Feng
    DIABETES OBESITY & METABOLISM, 2022, 24 (10) : 1967 - 1975